title: 43rd Annual Meeting of the American Society of Hematology, December 7-11, 2001, Orlando, Florida.
authors.forename: Amy I
authors.initials: AI
authors.lastname: D'Orazio
authors.forename: Maxine D
authors.initials: MD
authors.lastname: Fisher
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D017322:Clinical Trials, Phase II as Topic; D003226:Congresses as Topic; D005260:Female; D006801:Humans; D016399:Lymphoma, T-Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012720:Severity of Illness Index; D012955:Societies, Medical; D015996:Survival Rate; D016896:Treatment Outcome